Raymond James Financial Services Advisors, Inc. Vaxart, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 188,384 shares of VXRT stock, worth $77,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
188,384
Previous 196,818
4.29%
Holding current value
$77,237
Previous $131,000
22.14%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding VXRT
# of Institutions
29Shares Held
4.44MCall Options Held
0Put Options Held
0-
Marshall Wace, LLP London, X01.95MShares$800,7450.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$727,4810.0% of portfolio
-
Xtx Topco LTD London, X094.3KShares$38,6450.0% of portfolio
-
Hbk Sorce Advisory LLC Erie, PA75.1KShares$30,7980.0% of portfolio
-
Beacon Capital Management, LLC60.3KShares$24,7280.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $51.9M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...